713.9K XNAS Volume
XNAS 24 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Leonard E. Post | Director | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 17 Mar 2025 | 1,000 | 0 | - | 28 | 28,000 | Common Stock |
| Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 17 Mar 2025 | 1,000 | 1,000 | - | 0.6 | 600 | Common Stock |
| Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2025 | 1,000 | 130,077 | - | - | Director Stock Option (right to buy) | |
| Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 1,000 | 131,077 | - | - | Director Stock Option (right to buy) | |
| Leonard E. Post | Director | Sale of securities on an exchange or to another person at price $ 28.61 per share. | 18 Feb 2025 | 1,000 | 0 | - | 28.6 | 28,610 | Common Stock |
| Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 18 Feb 2025 | 1,000 | 1,000 | - | 0.6 | 600 | Common Stock |
| Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2025 | 1,000 | 132,077 | - | - | Director Stock Option (right to buy) | |
| Leonard E. Post | Director | Sale of securities on an exchange or to another person at price $ 29.66 per share. | 13 Jan 2025 | 1,000 | 0 | - | 29.7 | 29,660 | Common Stock |
| Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 13 Jan 2025 | 1,000 | 1,000 | - | 0.6 | 600 | Common Stock |
| Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2024 | 1,000 | 133,077 | - | - | Stock Option | |
| Leonard E. Post | Director | Sale of securities on an exchange or to another person at price $ 28.84 per share. | 16 Dec 2024 | 1,000 | 0 | - | 28.8 | 28,840 | Common Stock |
| Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 16 Dec 2024 | 1,000 | 1,000 | - | 0.6 | 600 | Common Stock |
| Hong Fang Song | Director | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 16 Dec 2024 | 700,000 | 3,003,931 | - | 28 | 19,600,000 | Common Stock |
| Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 06 Dec 2024 | 1,000 | 1,000 | - | 0.6 | 600 | Common Stock |
| Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 1,000 | 134,077 | - | - | Stock Option | |
| Leonard E. Post | Director | Sale of securities on an exchange or to another person at price $ 34.98 per share. | 06 Dec 2024 | 250 | 0 | - | 35.0 | 8,744 | Common Stock |
| Leonard E. Post | Director | Sale of securities on an exchange or to another person at price $ 34.40 per share. | 06 Dec 2024 | 750 | 250 | - | 34.4 | 25,798 | Common Stock |
| Vijay Kasturi | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 132,600 | 132,600 | - | - | Stock Option (Right to Buy) | |
| Victor Tong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 15,600 | 15,600 | - | - | Stock Option (Right to Buy) | |
| Brian Liu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 15,600 | 15,600 | - | - | Stock Option (Right to Buy) | |
| Ambaw Bellete | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 175,500 | 175,500 | - | - | Stock Option (Right to Buy) | |
| Arthur Kuan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 397,800 | 397,800 | - | - | Stock Option (Right to Buy) | |
| Corleen M. Roche | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 93,600 | 93,600 | - | - | Stock Option (Right to Buy) | |
| Hong Fang Song | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 15,600 | 15,600 | - | - | Stock Option (Right to Buy) | |
| Susan E. Graf | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 15,600 | 15,600 | - | - | Stock Option (Right to Buy) | |
| Leonard E. Post | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 15,600 | 15,600 | - | - | Stock Option (Right to Buy) | |
| Hong Fang Song | Director | Sale of securities on an exchange or to another person at price $ 35.36 per share. | 29 Aug 2024 | 424,210 | 586,982 | - | 35.4 | 15,000,066 | Common Stock |
| Hong Fang Song | Director | Sale of securities on an exchange or to another person at price $ 35.36 per share. | 29 Aug 2024 | 226,245 | 3,703,931 | - | 35.4 | 8,000,023 | Common Stock |
| Hong Fang Song | Director | 29 Jan 2024 | 350,771 | 350,771 | - | - | Common Stock | ||
| Hong Fang Song | Director | 29 Jan 2024 | 3,930,176 | 3,930,176 | - | - | Common Stock | ||
| Hong Fang Song | Director | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 29 Jan 2024 | 263,157 | 613,928 | - | 19 | 4,999,983 | Common Stock |
| Hong Fang Song | Director | 29 Jan 2024 | 1,011,192 | 1,011,192 | - | - | Common Stock | ||
| Hong Fang Song | Director | 29 Jan 2024 | 37,474,236 | 0 | - | - | Series E Preferred Stock | ||
| Hong Fang Song | Director | 29 Jan 2024 | 3,378,758 | 0 | - | - | Series D Preferred Stock | ||
| Hong Fang Song | Director | 29 Jan 2024 | 6,262,967 | 0 | - | - | Series C Preferred Stock | ||
| Hong Fang Song | Director | 29 Jan 2024 | 3,344,608 | 0 | - | - | Series B Preferred Stock | ||
| Corleen M. Roche | CFO & Secretary | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 29 Jan 2024 | 2,000 | 2,000 | - | 19 | 38,000 | Common Stock |
| Vijay Kasturi | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 29 Jan 2024 | 1,315 | 1,315 | - | 19 | 24,985 | Common Stock |
| Corleen M. Roche | CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 492,920 | 492,920 | - | - | Stock Option |